<unk>  was initially derived by Dale Kempf, et al. from a moderately potent and orally bioavailable small molecule, A-80987. The P3 and P2′ heterocyclic groups of A-80987 were redesigned to create an analogue, now known as<unk> , with improved pharmacokinetic properties to the original. Full details of the synthesis of<unk>  were first published by scientists from Abbott Laboratories. :650px In the first step shown, an aldehyde derived from phenylalanine is treated with zinc dust in the presence of vanadium(III) chloride. This results in a pinacol coupling reaction which dimerizes the material to provide an intermediate which is converted to its epoxide and then reduced to (2S,3S,5S)-2,5-diamino-1,6-diphenylhexan-3-ol. Importantly, this retains the absolute stereochemistry of the amino acid precursor. The diamine is then treated sequentially with two thiazole derivatives, each linked by an amide bond, to provide<unk> .
Ritonavir
Amprenavir
Saquinavir
Fosamprenavir
Indinavir
Nelfinavir
Atazanavir
Entecavir